Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Biotalys NV ( (DE:86C) ) has shared an update.
Biotalys has received a positive recommendation from the Dutch regulatory authority CTGB for the approval of its biofungicide EVOCA in the European Union, marking a significant milestone for the company. This recommendation highlights the promise of Biotalys’ innovative AGROBODY™ technology and could strengthen its position in the AgTech sector, although further regulatory steps in Europe and ongoing reviews in the United States remain before full market approval can be achieved.
More about Biotalys NV
Biotalys is an Agricultural Technology company focused on developing protein-based biocontrol solutions to offer sustainable alternatives to traditional chemical pesticides. Founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology), it is based in Ghent, Belgium, and listed on Euronext Brussels since July 2021. The company leverages its AGROBODY™ technology platform to create a diverse product pipeline aimed at enhancing crop protection across the agricultural value chain.
YTD Price Performance: 5.23%
Average Trading Volume: 741
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €129.2M
See more insights into 86C stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “…Significantly Extend the Reach and Lethality of our Fleet”: Boeing Stock (NYSE:BA) Slips Despite Successful MQ-25A Test
- “Direct Result of Your Feedback….” Microsoft Stock (NASDAQ:MSFT) Slips as The Option to Skip Updates Emerges
- Elon Musk’s 2018 Stock Shares Go Live, Tesla Stock (NASDAQ:TSLA) Slips

